Epipole
Epipole is an innovative, engineering-led company tackling the causes of preventable blindness.
Epipole has raised €3.2M across 2 funding rounds from 2 investors, most recently a round in Jan 2022. Based in Rosyth, UK; founded 2011; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€3.2M
€3,214,410
Funding rounds
2
Investors
2
distinct backers
Active since
2020-06
latest 2022-01
Funding by year
EUR raised per yearEpipole — funding by year — interactive chart.
Data table
| Epipole — funding by year | |
|---|---|
| 2020 | €1.7M |
| 2022 | €1.6M |
Signals
High confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Exit likelihood6
base rate 11% (2+ rounds)
- ▼ No recent equity round (debt-only or quiet)
Timing: dormant vs cohort gap · momentum flat. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
2 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-21 | Other | €1.6M | Greenwood Way Capital,Scottish Enterprise | View deal → |
| 2020-06-24 | Other | €1.7M | Greenwood Way Capital | View deal → |